{
  "authors": [
    {
      "author": "Florian Huemer"
    },
    {
      "author": "Thomas Melchardt"
    },
    {
      "author": "Wolfgang Tränkenschuh"
    },
    {
      "author": "Daniel Neureiter"
    },
    {
      "author": "Gerhard Moser"
    },
    {
      "author": "Teresa Magnes"
    },
    {
      "author": "Lukas Weiss"
    },
    {
      "author": "Alexander Schlattau"
    },
    {
      "author": "Clemens Hufnagl"
    },
    {
      "author": "Gerda Ricken"
    },
    {
      "author": "Romana Höftberger"
    },
    {
      "author": "Richard Greil"
    },
    {
      "author": "Alexander Egle"
    }
  ],
  "doi": "10.1186/s12885-015-2020-4",
  "publication_date": "2015-12-24",
  "id": "EN114951",
  "url": "https://pubmed.ncbi.nlm.nih.gov/26694863",
  "source": "BMC cancer",
  "source_url": "",
  "licence": "CC BY",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "We present the case of a 60-year old female patient who developed paraneoplastic cerebellar degeneration upon locoregional recurrence of a poorly differentiated spindle cell carcinoma of the nasal cavity and paranasal sinus. The neurological symptoms, especially ataxia, stabilized after resection of tumor recurrence and concomitant chemoradiotherapy whereas anti-Hu-antibodies remained positive. Despite the unfavorable prognosis of paraneoplastic neurological disorders associated with onconeural antibodies, the patient achieved long-standing stabilization of neurological symptoms."
}